Major indices were in the green earlier on Wednesday as traders digested more bank earnings and another key inflation report.

New York State Common Retirement Fund trimmed its Regeneron stake by 5% in Q1, selling over 6,800 shares worth millions.

In a report released today, Chris Schott from J.P. Morgan maintained a Hold rating on Amgen, with a price target of $300.00. The company’s shares closed last Friday at $295.27. Schott covers the ...

Oversea Chinese Banking Corp Ltd acquired a $30.17 million stake in Regeneron Pharmaceuticals during the first quarter, ...

Major indices closed higher on Monday as traders continued to monitor trade headlines ahead of key inflation data and the ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) is one of the 11 best debt-free stocks to invest in right now. The company ...

Analysts have recently evaluated Regeneron Pharmaceuticals and provided 12-month price targets. The average target is $769.35, accompanied by a high estimate of $975.00 and a low estimate of $547.00.

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s stance on vaccines ...

Shares of Centene Corp (CNC) traded 40% lower on Wednesday after several brokerages lowered their price target on the stock on the heels of the health insurer withdrawing its 2025 financial guidance.

Regeneron Pharmaceuticals said on Wednesday the U.S. Food and Drug Administration has approved its drug for a type of blood cancer called multiple myeloma that has recurred in patients who had ...

JP Morgan Chase & Co (NYSE:JPM) shares are trending on Wednesday. Here's a look at what's going on.